Saphris Asenapine Ruling Is Bounced Back By US Appeals Court
• By Aidan Fry
A Delware district court must reconsider whether a key US patent protecting Allergan's asenapine-based Saphris antipsychotic is valid and/or infringed by generic filers • Source: Shutterstock
